Tag: vaccine efficacy

Towards Technofascism: Vaccine Passports and the Inequality Virus in the Debate

Tina Marie (Ms. Cat)

Towards Technofascism: Vaccine Passports and the Inequality Virus in the Debate

Environmental activist and writer Chet Bowers claimed that their social agenda includes the imposition of barriers to people’s ability to vote; the use of the prison system to control a large segment of the poor and non-white population; the intertwining of fundamentalist religions and segments of government focused on national security; and the use of the military to globalize the American way of life; the suppression of basic human rights, especially for women; the undermining of the rights of workers to organize in order to oppose being exploited; and the authorization of fraudulent elections in which the

Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

Tina Marie (Ms. Cat)

Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

Results of the study: COVID-19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated. Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern: that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralising antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID-19 disease via antibody-dependent enhancement (ADE). This risk is sufficiently obscured in clinical trial protocols and consent forms for ongoing COVID-19 vaccine trials that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Related:

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us

Phase III trials evaluated mild, not severe, disease!

Does the FDA think these data justify full approval of Covid Vaxx?

Tina Marie (Ms. Cat)

Does the FDA think these data justify full approval of Covid Vaxx?

Prior to the preprint, my view, along with a group of around 30 clinicians, scientists, and patient advocates, was that there were simply too many open questions about all covid-19 vaccines to support approving any this year. The preprint has, unfortunately, addressed very few of those open questions, and has raised some new ones.

Unfortunately, it was just given full approval by the FDA.

‘No need to rush’: Senator warns of FDA’s shortcuts to full approval of COVID-19 vaccine

Tina Marie (Ms. Cat)1 Comment

‘No need to rush’: Senator warns of FDA’s shortcuts to full approval of COVID-19 vaccine (Archived)

“I see no need to rush the FDA approval process for any of the three COVID-19 vaccines. Expediting the process appears to only serve the political purpose of imposing and enforcing vaccine mandates,” Mr. Johnson wrote in the letter, a copy of which was obtained by The Washington Times.

…

U.S. Surgeon General Vivek Murthy told “Fox News Sunday” that moving the Pfizer vaccine from “emergency” to “full approval” would make mandates more appealing.

…

Former FDA Commissioner Scott Gottlieb, who is on the Pfizer board of directors, also said the full approval will prompt more vaccine mandates.

Related:

Gottlieb’s Pfizer Announces $1.95 Billion Deal with Feds for COVID-19 Vaccine

Just hours before the Pfizer vaccine news became public, Gottlieb appeared on CNBC’s Squawk Box to explain that any vaccine will need to be administered on an annual basis.

Source.

Some more notes that I made, about Gottlieb and the coronavirus, in March 2020.